US2014262858A1PendingUtilityA1
Packaging for alitretinoin
Est. expiryOct 21, 2031(~5.2 yrs left)· nominal 20-yr term from priority
B65D 81/2023B65D 77/04B65D 81/266B65D 81/2084
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to the use of an oxygen absorber and silica gel desiccant in a vacuum-sealed pack for the reduction or prevention of oxidative degradation of alitretinoin.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method for the reduction or prevention of oxidative degradation of alitretinoin comprising an oxygen absorber and a silica gel desiccant in a vacuum-sealed pack.
2 . A vacuum-sealed pack comprising alitretinoin, an oxygen absorber and a silica gel desiccant.
3 . A vacuum-sealed pack comprising a pharmaceutical composition which includes alitretinoin, an oxygen absorber, and a silica gel desiccant.
4 . The vacuum-sealed pack of claim 1 , 2 , or 3 , wherein the oxygen absorber is an inorganic metal based oxygen absorber; an ascorbic acid based absorber; an enzymatic absorber; or a polymer based oxygen absorber.
5 . The vacuum-sealed pack of claim 1 , 2 , or 3 , wherein the oxygen absorber is StabilOx®.Join the waitlist — get patent alerts
Track US2014262858A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.